AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI
| AIFU Stock | 1.06 0.02 1.85% |
Slightly above 61% of Fanhua's investor base is looking to short. The analysis of the overall prospects from investing in Fanhua Inc suggests that many traders are, at the present time, alarmed. Fanhua's investing sentiment can be driven by a variety of factors including economic data, Fanhua's earnings reports, geopolitical events, and overall market trends.
Fanhua |
GUANGZHOU, China, Nov. 29, 2024 -- AIX Inc. , a leading independent technology-driven financial services provider in China, today announced that it has entered into a strategic transaction agreement with BGM Group Ltd. , a leading global provider of premium pharmaceutical products and services. Pursuant to the Agreement, AIX agreed to transfer the equity interests of its intelligent platform consisting
Read at finance.yahoo.com
 |
Fanhua Fundamental Analysis
We analyze Fanhua's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fanhua using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fanhua based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Fanhua is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Fanhua Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fanhua stock to make a market-neutral strategy. Peer analysis of Fanhua could also be used in its relative valuation, which is a method of valuing Fanhua by comparing valuation metrics with similar companies.
Peers
Fanhua Related Equities
| HUIZ | Huize Holding | 28.23 | ||||
| GOCO | GoHealth | 0.79 | ||||
| EHTH | EHealth | 0.48 | ||||
| AJG | Arthur J | 0.35 | ||||
| ERIE | Erie Indemnity | 0.00 | ||||
| MMC | Marsh McLennan | 0.33 | ||||
| BRO | Brown Brown | 0.64 | ||||
| AON | Aon PLC | 0.69 | ||||
| WTW | Willis Towers | 1.38 | ||||
| ZBAO | Zhibao Technology | 2.12 |
Additional Tools for Fanhua Stock Analysis
When running Fanhua's price analysis, check to measure Fanhua's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fanhua is operating at the current time. Most of Fanhua's value examination focuses on studying past and present price action to predict the probability of Fanhua's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fanhua's price. Additionally, you may evaluate how the addition of Fanhua to your portfolios can decrease your overall portfolio volatility.